Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-08-21

Clinical Trial Update: Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne [Phase 2]

View source ↗

Summary

Phase 2 results are reported for a light-dose ranging study of photodynamic therapy using Levulan (aminolevulinic acid) plus blue light versus vehicle plus blue…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levulan (aminolevulinic acid)

Snippet

Sponsor: DUSA Pharmaceuticals, Inc. | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2009-08-21